<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35124556</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>05</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Percutaneous endoscopic gastrostomy (PEG) as a procedure to improve survival of patients with amyotrophic lateral sclerosis (ALS)].</ArticleTitle><Pagination><StartPage>102286</StartPage><MedlinePgn>102286</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102286</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2022.102286</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(22)00006-3</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Greoles Cano</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Facultat de Medicina i Ci&#xe8;ncies de la Salut, Universitat de Barcelona, Barcelona, Espa&#xf1;a. Electronic address: jordi.greoles@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><VernacularTitle>La gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea (PEG) como procedimiento para mejorar la supervivencia de los pacientes con esclerosis lateral amiotr&#xf3;fica (ELA).</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005774" MajorTopicYN="N">Gastrostomy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>6</Day><Hour>20</Hour><Minute>38</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35124556</ArticleId><ArticleId IdType="pmc">PMC8829086</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2022.102286</ArticleId><ArticleId IdType="pii">S0212-6567(22)00006-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Scott A. On the treatment trail for ALS. Nature. 2017;550:S120&#x2013;S121.</Citation><ArticleIdList><ArticleId IdType="pubmed">29045376</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Rodr&#xed;guez E., Azagra R., G&#xf3;mez-Batiste X., Povedano M. La esclerosis lateral amiotr&#xf3;fica (ELA) desde la Atenci&#xf3;n Primaria Epidemiolog&#xed;a y caracter&#xed;sticas cl&#xed;nico-asistenciales. Aten Primaria. 2021;53</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435918</ArticleId><ArticleId IdType="pubmed">34509895</ArticleId></ArticleIdList></Reference><Reference><Citation>Carb&#xf3; Perseguer J., Madej&#xf3;n Seiz A., Romero Portales M., Mart&#xed;nez Hern&#xe1;ndez J., Mora Pardina J.S., Garc&#xed;a-Samaniego J. La gastrostom&#xed;a endosc&#xf3;pica percut&#xe1;nea en pacientes diagnosticados de esclerosis lateral amiotr&#xf3;fica: mortalidad y complicaciones. Neurologia. 2019;34:582&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pubmed">29599075</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Eraso C., L&#xf3;pez Ram&#xed;rez C., Asensio Cruz M.I., Puig S&#xe1;nchez F., Barrot Cort&#xe9;s E., Jara Palomares J. Impacto de la gastrostom&#xed;a percut&#xe1;nea en la supervivencia de pacientes con esclerosis lateral amiotr&#xf3;fica. Rev Esp Patol Torac. 2021;33:16&#x2013;23.</Citation></Reference><Reference><Citation>Mitsumoto H., Davidson M., Moore D., Gad N., Brandis M., Ringel S., et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003;4:177&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">13129795</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-G&#xf3;mez J.J., Ballesteros-Pomar M.D., Torres-Torres B., Pintor-De la Maza B., Penacho-L&#xe1;zaro M.A., Palacio-Mures J.M., et al. Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS) Nutrients. 2021;13:2765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8401888</ArticleId><ArticleId IdType="pubmed">34444925</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>